The principles and definitions of the biological safety described in MS&T Biological Hygiene Plan. Biohazard classifications, biosafety containment levels (BSL1-4 & ABSL1-4), infectious agent Risk Groups (RG1-4), infectious dose, concentration, and immune status are defined in this section.
Biosafety levels (BSLs) prescribe specific combinations of laboratory practices, safety equipment, and facility design. These criteria are tailored to the operations performed, suspected routes of transmission, and overall laboratory function.
Scope: Work with well-characterized agents not known to consistently cause disease in healthy adult humans, presenting minimal hazard to personnel and the environment.
Containment & Facilities: Special containment equipment and dedicated facility features are generally not required.
Personnel & Supervision: Staff receive specific procedural training and operate under the supervision of a scientist with general microbiology or related expertise.
Scope: Work involving agents of moderate potential hazard to personnel and the environment.
Containment & Equipment: Procedures generating infectious aerosols or splashes must be conducted within Biosafety Cabinets (BSCs) or other physical containment. Extreme precautions are enforced for contaminated sharps.
Facility Access & Personnel: Access is restricted during active work. Personnel must hold specific training in handling pathogenic agents and work under competent scientific direction.
Scope: Research, diagnostic, or teaching facilities working with indigenous or exotic agents that pose a risk of serious or potentially lethal infection via aerosol transmission.
Containment & Equipment: All manipulations of infectious materials must occur within BSCs, physical containment devices, or by personnel equipped with specialized PPE.
Facility & Personnel: The facility features specialized engineering controls (e.g., directional airflow). Staff undergo specialized training in handling hazardous agents under the guidance of experienced scientists.
Scope: Work with dangerous and exotic agents posing a high individual risk of life-threatening, aerosol-transmitted laboratory infections.
Animal Biosafety Levels establish containment practices, equipment, and facility standards for in vivo experiments with infected animals. In general, animal biosafety levels correspond to their in vitro BSL counterparts.
Scope: Work involving animals infected with well-characterized agents not known to cause disease in healthy adult humans, presenting minimal hazard to personnel and the environment.
Scope: Work involving animals infected with agents associated with human disease (hazards from ingestion, percutaneous exposure, or mucous membrane contact). Builds upon ABSL-1 standards.
Containment & Equipment: Procedures creating aerosols or splashes are conducted inside physical containment devices (e.g., BSCs).
Facility Access & Personnel: Facility access is restricted exclusively to essential personnel who are informed of potential hazards. Staff receive specific training in handling pathogens and infected animals.
Scope: Work with animals infected with indigenous or exotic agents presenting a risk of aerosol transmission and serious or lethal disease. Builds upon ABSL-2 standards.
Containment & Engineering: All manipulations of animals and infectious materials require physical containment or specialized PPE. Facilities require specialized engineering controls and negative-pressure HVAC systems.
Personnel: Personnel undergo advanced training in handling animals infected with high-consequence pathogens under expert scientific oversight.
Scope: Work involving dangerous or exotic agents posing high individual risks of life-threatening disease, aerosol transmission, or agents with unknown transmission risks.
Per the NIH Guidelines, investigators must perform an initial risk assessment based on the Risk Group (RG) of the parent organism, categorized by human pathogenicity:
Risk Group 1 (RG1): Agents not associated with disease in healthy adult humans.
Risk Group 2 (RG2): Agents associated with human disease that is rarely serious, for which preventive or therapeutic interventions are typically available.
Risk Group 3 (RG3): Agents associated with serious or lethal human disease, for which preventive or therapeutic interventions may be available.
Risk Group 4 (RG4): Agents likely to cause serious or lethal human disease, for which preventive or therapeutic interventions are usually unavailable.
The NIH Guidelines define standard practices, containment equipment, and facility requirements across specialized research settings:
Standard Research Laboratories: Biosafety Levels 1 through 4 (BL1 to BL4)
Large-Scale Operations (>10 Liters): Large scale (BL-1 Large scale to BL-4 Large scale): large scale (over 10 liters) research and production governed by Good Large Scale Practices (GLSP)
Plant Research (Greenhouses): B -1P through BL-4P
Animal Research (Whole Animals): BL-1N through BL-4N
Follow Institutional Biosafety Committee